Literature DB >> 18775772

Effect of Brazilian copaiba oils on Leishmania amazonensis.

Adriana O Santos1, Tânia Ueda-Nakamura, Benedito P Dias Filho, Valdir F Veiga Junior, Angelo C Pinto, Celso Vataru Nakamura.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Copaiba oil has been used in folk medicine since the 19th century. The use of copaiba oils to treat leishmaniasis is cited in several ethnopharmacological studies. Nevertheless, the potential antileishmania of copaiba oils had not been studied. AIM OF THE STUDY: Eight different kinds of Brazilian copaiba oils were screened for antileishmanial activity.
MATERIALS AND METHODS: The antiproliferative effect of copaiba oil on promastigote and amastigote axenic were determined. To determine the survival index peritoneal macrophage were infected with promastigotes of Leishmania amazonensis and treated with copaiba oil. The cytotoxic effect of copaiba oil was assessed on macrophage strain J774G8 by assay of sulforhodamine B.
RESULTS: Copaiba oils showed variable levels of activity against promastigote forms with IC(50) values in the range between 5 and 22microg/mL. The most active oil was that from Copaifera reticulata (collected in Pará State, Brazil) with IC(50) values of 5, 15, and 20microg/mL for promastigote, axenic amastigote and intracellular amastigote forms, respectively. Amphotericin B showed IC(50) of 0.058 and 0.231microg/mL against promastigote and amastigote forms, respectively. Cytotoxicity assay showed that this copaiba oil obtained from Copaifera reticulata showed low cytotoxicity against J774G8 macrophages.
CONCLUSION: Copaiba oils showed significant activity against the parasite Leishmania amazonensis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775772     DOI: 10.1016/j.jep.2008.08.007

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  25 in total

1.  Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model.

Authors:  Olena Sivak; Pavel Gershkovich; Molly Lin; Ellen K Wasan; Jinying Zhao; David Owen; John G Clement; Kishor M Wasan
Journal:  Lipids Health Dis       Date:  2011-08-08       Impact factor: 3.876

2.  Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.

Authors:  Pramod K Gupta; Anil K Jaiswal; Shalini Asthana; Venkatesh Teja B; Prashant Shukla; Minakshi Shukla; Neeti Sagar; Anuradha Dube; Srikanta K Rath; Prabhat R Mishra
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

3.  Beta-carboline-3-carboxamide derivatives as promising antileishmanial agents.

Authors:  R B Pedroso; L T D Tonin; T Ueda-Nakamura; B P Dias Filho; M H Sarragiotto; C V Nakamura
Journal:  Ann Trop Med Parasitol       Date:  2011-12

4.  Chemopreventive effect of Copaifera langsdorffii leaves hydroalcoholic extract on 1,2-dimethylhydrazine-induced DNA damage and preneoplastic lesions in rat colon.

Authors:  Juliana Marques Senedese; Jacqueline Morais Alves; Ildercílio Mota de Souza Lima; Erick Augusto Pedroso de Andrade; Ricardo Andrade Furtado; Jairo Kenupp Bastos; Denise Crispim Tavares
Journal:  BMC Complement Altern Med       Date:  2013-01-07       Impact factor: 3.659

5.  Copaiba Oil: An Alternative to Development of New Drugs against Leishmaniasis.

Authors:  Adriana Oliveira Dos Santos; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Valdir Florêncio da Veiga Junior; Celso Vataru Nakamura
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-12       Impact factor: 2.629

6.  Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury.

Authors:  Adriano Guimarães-Santos; Diego Siqueira Santos; Ijair Rogério Santos; Rafael Rodrigues Lima; Antonio Pereira; Lucinewton Silva de Moura; Raul Nunes Carvalho; Osmar Lameira; Walace Gomes-Leal
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-19       Impact factor: 2.629

7.  Therapeutic switching: from antidermatophytic essential oils to new leishmanicidal products.

Authors:  Emeline Houël; German Gonzalez; Jean-Marie Bessière; Guillaume Odonne; Véronique Eparvier; Eric Deharo; Didier Stien
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-13       Impact factor: 2.743

8.  Effects of the extract and glycoalkaloids of Solanum lycocarpum St. Hill on Giardia lamblia trophozoites.

Authors:  Gilmarcio Z Martins; Raquel R D Moreira; Cleopatra S Planeta; Adélia E Almeida; Jairo K Bastos; Lígia Salgueiro; Carlos Cavaleiro; Maria do Céu Sousa
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

Review 9.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

10.  Eugenia uniflora L. Essential Oil as a Potential Anti-Leishmania Agent: Effects on Leishmania amazonensis and Possible Mechanisms of Action.

Authors:  Klinger Antonio da Franca Rodrigues; Layane Valéria Amorim; Jamylla Mirck Guerra de Oliveira; Clarice Noleto Dias; Denise Fernandes Coutinho Moraes; Eloisa Helena de Aguiar Andrade; Jose Guilherme Soares Maia; Sabrina Maria Portela Carneiro; Fernando Aécio de Amorim Carvalho
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.